Colorectal metastases: Ablation

Interventional Oncology: Principles and Practice

Volumn , Issue , 2008, Pages 264-272

  Solbiati, Luigi ^a  

^a GENERAL HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84932625959     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511722226.023     Document Type: Chapter

References (47)

1. Fahy BN, Jarnagin WR. Evolving techniques in the treatment of liver colorectal metastases: Role of laparoscopy, radiofrequency ablation, microwave coagulation, hepatic arterial chemotherapy, indications and contraindications for resection, role of transplantation, and timing of chemotherapy. Surg Clin North Am, 2006; 86: 1005-1022.
2. Nordlinger B and Rougier P. Nonsurgical methods for liver metastases including cryotherapy, radiofrequency ablation and infusional treatment: What's new in 2001? Curr Opin Oncol, 2002; 14: 420-423.
3. Sica GT, Ji H, and Ros PR. CT and MR imaging of hepatic metastases. Am J Roentgenol, 2000; 174: 691-698.
4. Valls C, Andia E, Sanchez A, et al. Hepatic metastases from colorectal cancer: Preoperative detection and assessment of resectability with helical CT. Radiology, 2001; 218: 55-60.
5. Quaia E, Bertolotto M, Forgacs B, et al. Detection of liver metastases by pulse inversion harmonic imaging during Levovist late phase: Comparison with conventional ultrasound and helical CT in 160 patients. Eur Radiol, 2003; 13: 475-483.
6. Albrecht T, Blomley MJ, Burns PN, et al. Improved detection of hepatic metastases with pulse-inversion US during the liver-specific phase of SHU 508A: Multicenter Study. Radiology, 2003; 227: 361-370.
7. Fong Y, Salo J. Surgical therapy of hepatic colorectal metastasis. Semin Oncol, 1999; 26: 514-523.
8. Hugh TJ, Kinsella AR, and Poston GJ. Management strategies for colorectal liver metastases-Part I. Surg Oncol, 1997; 6: 19-30.
9. Liu LX, Zhang WH, and Jiang HC. Current treatment for liver metastases from colorectal cancer. World J Gastroenterol, 2003; 9: 193-200.
10. Yoon SS and Tanabe KK. Surgical treatment and other regional treatments for colorectal cancer liver metastases. Oncologist, 1999; 4: 197-208.
11. McKay A, Dixon E, and Taylor M. Current role of radiofrequency ablation for the treatment of colorectal liver metastases. Br J Surg, 2006; 93: 1192-1201.
12. Goldberg SN, Gazelle GS, and Mueller PR. Thermal ablation therapy for focal malignancy: A unified approach to underlying principles, techniques, and diagnostic imaging guidance. Am J Roentgenol, 2000; 174: 323-331.
13. Goldberg SN, Solbiati L, Hahn PF, et al. Large-volume tissue ablation with radiofrequency by using a clustered, internally cooled electrode technique: Laboratory and clinical experience in liver metastases. Radiology, 1998; 209: 371-379.
14. Lencioni R, Goletti O, Armillotta N, et al. Radiofrequency thermal ablation of liver metastasis with cooledtip electrode needle: Results of a pilot clinical trial. Eur Radiol, 1998; 8: 1205-1211.
15. Pacella CM, Valle D, Bizzarri G, et al. Percutaneous laser ablation in patients with isolated unresectable liver metastases from colorectal cancer: Results of a phase II study. Acta Oncologica, 2006; 45: 77-83.
16. Rossi S, Buscarini E, Garbagnati F, et al. Percutaneous treatment of small hepatic tumors by an expandable RF needle electrode. Am J Roentgenol, 1998; 170: 1015-1022.
17. Solbiati L, Goldberg SN, Ierace T, et al. Hepatic metastases: Percutaneous radio-frequency ablation with cooled-tip electrodes. Radiology, 1997; 205: 367-373.
18. Solbiati L, Ierace T, Goldberg SN, et al. Percutaneous US-guided radio-frequency tissue ablation of liver metastases: Treatment and follow-up in 16 patients. Radiology, 1997; 202: 195-203.
19. Vogl TJ, Straub R, Eichler K, et al. Colorectal carcinoma metastases in liver: Laser-induced interstitial thermotherapy-local tumor control rate and survival data. Radiology, 2004; 230: 450-458.
20. DeBaere T, Bessoud B, Dromain C, et al. Percutaneous radiofrequency ablation of hepatic tumors during temporary venous occlusion. Am J Roentgenol, 2002; 178: 53-59.
21. Rhim H, Goldberg SN, Dodd GD 3rd, et al. Essential techniques for successful radio-frequency thermal ablation of malignant hepatic tumors. Radiographics, 2001; 21: S17-35.
22. Goldberg SN, Kamel IR, Kruskal JB, et al. Radiofrequency ablation of hepatic tumors: Increased tumor destruction with adjuvant liposomal doxorubicin therapy. Am J Roentgenol, 2002; 179: 93-101.
23. Abitabile P, Hartl U, Lange J, et al. Radiofrequency ablation permits an effective treatment for colorectal liver metastasis. Eur J Surg Oncol, 2007; 33: 67-71.
24. Berber E, Pelley R, and Siperstein AE. Predictors of survival after radiofrequency thermal ablation of colorectal cancer metastases to the liver: A prospective study. J Clin Oncol, 2005; 23: 1358-1364.
25. Leen E and Horgan PG. Radiofrequency ablation of colorectal liver metastases. Surg Oncol, 2007; 16: 47-51.
26. Pereira PL. Actual role of radiofrequency ablation of liver metastases. Eur Radiol, 2007; 17: 2062-2070.
27. Solbiati L, Livraghi T, Goldberg SN, et al. Percutaneous radiofrequency ablation of hepatic metastases from colorectal cancer: Long-term results in 117 patients. Radiology, 2001; 221: 159-166.
28. TonoliniMand Solbiati L. Ultrasound imaging in tumor ablation. In: vanSonnenberg E, McMullen W, Solbiati L, (eds), Tumor Ablation: Principles and Practice pp. 135-147. New York: Springer, 2005.
29. Solbiati L, Tonolini M and Ierace T. Guidance of percutaneous tumor ablation. In: Lencioni R, (ed), Enhancing the Role of Ultrasound with Contrast Agents pp. 69-76. Heidelberg: Springer, 2006.
30. Solbiati L, Cova L, and Ierace T. US-CT fusion for performing radiofrequency ablation of small or poorly visualized liver tumors. Eur Radiol, 2005; 15 (Suppl 3): C45.
31. Anderson GS, Brinkmann F, Soulen MC, et al. FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation. Clin Nucl Med, 2003; 28: 192-197.
32. Vossen JA, Buijs M, and Kamel IR. Assessment of tumor response onMRimaging after locoregional therapy. Tech Vasc Interv Radiol, 2006; 9: 125-132.
33. Koh DM, Scurr E, Collins DJ, et al. Colorectal hepatic metastases: Quantitative measurements using single-shot echo-planar diffusion-weightedMRimaging. Eur Radiol, 2006; 16: 1898-1905.
34. Taouli B, Vilgrain V, Dumont E, et al. Evaluation of liver diffusion isotropy and characterization of focal hepatic lesions with two single-shot echo-planar MR imaging sequences: Prospective study in 66 patients. Radiology, 2003; 226: 71-78.
35. Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases. Ann Surg, 1999; 230: 309-321.
36. Registry of Hepatic Metastases: Resection of the liver for colorectal carcinoma metastases: A multi-institutional study of indications for resection. Surgery, 1998; 103: 278-288.
37. Scheele J, Stang R, Altendorf-Hofmann A, et al. Resection of colorectal carcinoma metastases to the liver: A prognostic scoring system to improve case selection, based on 156 patients. Cancer, 1996; 77: 1254-1262.
38. Elias D, DeBaere T, Smayra T, et al. Percutaneous radiofrequency thermoablation as an alternative to surgery for treatment of liver tumour recurrence after hepatectomy. Br J Surg, 2002; 89: 752-756.
39. Gillams AR and Lees WR. Radio-frequency ablation of colorectal liver metastases in 167 patients. Eur Radiol, 2004; 14: 2261-2267.
40. Jakobs TF, Hoffmann RT, Trumm C, et al. Radiofrequency ablation of colorectal liver metastases: Mid-term results in 68 patients. Anticancer Res, 2006; 26: 671-680.
41. Lencioni R, Crocetti L, Cioni D, et al. Percutaneous radiofrequency ablation of hepatic colorectal metastases: Technique, indications, results and new promises. Invest Radiol, 2004; 39: 689-697.
42. Sorensen SM, Mortensen FV, and Nielsen DT. Radiofrequency ablation of colorectal liver metastases: Long-term survival. Acta Radiol, 2007; 48: 253-258.
43. Abdalla EK, Vauthey JN, Ellis LM, et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation and combined resection/ablation for colorectal liver metastases. Ann Surg, 2004; 239: 818-827.
44. DeBaere T, Risse O, Kuoch V, et al. Adverse events during radiofrequency treatment of 582 hepatic tumors. Am J Roentgenol, 2003; 181: 695-700.
45. Livraghi T, Solbiati L, Meloni MF, et al. Treatment of focal liver tumors with percutaneous radiofrequency ablation: Complications encountered in a multicenter study. Radiology, 2003; 226: 441-451.
46. Machi J, Oishi AJ, Sumida K, et al. Long-term outcome of radiofrequency ablation for unresectable liver metastases from colorectal cancer: Evaluation of prognostic factors and effectiveness in first-and second-line management. Cancer J, 2006; 12: 318-326.
47. Livraghi T, Solbiati L, Meloni F, et al. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: The "test of time" approach. Cancer, 2003; 97: 3027-3035.